SLC5A5 and breast cancer: In contrast, the potential effectiveness of radioiodide therapy in breast cancer depends on whether NIS becomes functionally expressed in malignant mammary cells, given that it is not functionally expressed in healthy cells, except during pregnancy and lactation.